XTX Topco Ltd bought a new position in HealthStream, Inc. (NASDAQ:HSTM – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 7,654 shares of the technology company’s stock, valued at approximately $214,000.
Other hedge funds also recently added to or reduced their stakes in the company. Parallel Advisors LLC increased its holdings in shares of HealthStream by 79.4% in the 4th quarter. Parallel Advisors LLC now owns 1,132 shares of the technology company’s stock worth $31,000 after acquiring an additional 501 shares during the period. GAMMA Investing LLC increased its stake in shares of HealthStream by 172.1% in the second quarter. GAMMA Investing LLC now owns 996 shares of the technology company’s stock valued at $28,000 after purchasing an additional 630 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in shares of HealthStream by 6.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 16,178 shares of the technology company’s stock valued at $432,000 after buying an additional 918 shares during the last quarter. State Board of Administration of Florida Retirement System lifted its holdings in HealthStream by 1.5% in the first quarter. State Board of Administration of Florida Retirement System now owns 78,749 shares of the technology company’s stock worth $2,134,000 after purchasing an additional 1,131 shares during the period. Finally, Ellsworth Advisors LLC boosted its stake in HealthStream by 6.8% during the 2nd quarter. Ellsworth Advisors LLC now owns 19,063 shares of the technology company’s stock valued at $532,000 after purchasing an additional 1,212 shares in the last quarter. 69.58% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other news, Director Tate Deborah Taylor sold 1,400 shares of the company’s stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $28.53, for a total value of $39,942.00. Following the transaction, the director now directly owns 22,326 shares of the company’s stock, valued at $636,960.78. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other HealthStream news, SVP Kevin P. O’hara sold 3,000 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total transaction of $84,090.00. Following the transaction, the senior vice president now directly owns 9,527 shares in the company, valued at $267,041.81. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Tate Deborah Taylor sold 1,400 shares of the company’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $28.53, for a total value of $39,942.00. Following the sale, the director now owns 22,326 shares of the company’s stock, valued at approximately $636,960.78. The disclosure for this sale can be found here. Insiders own 20.60% of the company’s stock.
HealthStream Stock Up 0.6 %
HealthStream (NASDAQ:HSTM – Get Free Report) last released its earnings results on Monday, July 22nd. The technology company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.02. The business had revenue of $71.56 million for the quarter, compared to the consensus estimate of $72.85 million. HealthStream had a net margin of 6.26% and a return on equity of 5.19%. The firm’s quarterly revenue was up 3.4% compared to the same quarter last year. During the same period last year, the firm posted $0.13 earnings per share. Equities analysts predict that HealthStream, Inc. will post 0.56 earnings per share for the current year.
HealthStream Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 16th. Shareholders of record on Monday, August 5th were paid a $0.028 dividend. The ex-dividend date was Monday, August 5th. This represents a $0.11 annualized dividend and a yield of 0.39%. HealthStream’s dividend payout ratio is presently 18.97%.
Analysts Set New Price Targets
HSTM has been the subject of several research reports. Canaccord Genuity Group raised their target price on HealthStream from $27.00 to $28.00 and gave the company a “hold” rating in a research note on Wednesday, July 24th. StockNews.com cut shares of HealthStream from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 24th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, HealthStream currently has a consensus rating of “Moderate Buy” and a consensus price target of $30.00.
Check Out Our Latest Research Report on HSTM
HealthStream Profile
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
See Also
- Five stocks we like better than HealthStream
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
- Stock Analyst Ratings and Canadian Analyst Ratings
- CarMax’s Impressive Rally: What Investors Should Watch Next
- How to buy stock: A step-by-step guide for beginners
- MarketBeat Week in Review – 9/23 – 9/27
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.